Liver biopsy for histological assessment - the case against
Percutaneous liver biopsy (LB) remains an important tool in the diagnosis and management of parenchymal liver diseases. In current practice, it is most frequently performed to assess the inflammatory grade and fibrotic stage of commonly encountered liver diseases, with the diagnostic role relegated...
Main Authors: | Sanai Faisal, Keeffe Emmet |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2010-01-01
|
Series: | The Saudi Journal of Gastroenterology |
Subjects: | |
Online Access: | http://www.saudijgastro.com/article.asp?issn=1319-3767;year=2010;volume=16;issue=2;spage=124;epage=132;aulast=Sanai |
Similar Items
-
Liver biopsy for histological assessment: The case in favor
by: Alswat Khalid, et al.
Published: (2010-01-01) -
Assessment of liver fibrosis: Noninvasive means
by: Poynard Thierry, et al.
Published: (2008-01-01) -
Personalized management of cirrhosis by non-invasive tests of liver fibrosis
by: Grace Lai-Hung Wong, et al.
Published: (2015-09-01) -
Biomarcadores para fibrosis hepática, avances, ventajas y desventajas
by: A. Cequera, et al.
Published: (2014-07-01) -
Noninvasive assessment of liver fibrosis: Serum markers and transient elastography (FibroScan) Evaluación no invasiva de fibrosis hepática: Marcadores séricos y elastografía transitoria (FibroScan)
by: J. C. Marín-Gabriel, et al.
Published: (2009-11-01)